Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Ocular Therapeutix (OCUL) Equity Ratio (2016 - 2025)

Ocular Therapeutix has reported Equity Ratio over the past 13 years, most recently at 0.81 for Q4 2025.

  • Quarterly results put Equity Ratio at 0.81 for Q4 2025, up 17.59% from a year ago — trailing twelve months through Dec 2025 was 0.81 (up 17.59% YoY), and the annual figure for FY2025 was 0.81, up 17.59%.
  • Equity Ratio for Q4 2025 was 0.81 at Ocular Therapeutix, up from 0.63 in the prior quarter.
  • Over the last five years, Equity Ratio for OCUL hit a ceiling of 0.81 in Q4 2025 and a floor of 0.03 in Q2 2023.
  • Median Equity Ratio over the past 5 years was 0.41 (2021), compared with a mean of 0.45.
  • Biggest five-year swings in Equity Ratio: tumbled 93.38% in 2023 and later soared 2799.88% in 2024.
  • Ocular Therapeutix's Equity Ratio stood at 0.43 in 2021, then tumbled by 44.82% to 0.24 in 2022, then surged by 52.56% to 0.36 in 2023, then soared by 90.47% to 0.69 in 2024, then increased by 17.59% to 0.81 in 2025.
  • The last three reported values for Equity Ratio were 0.81 (Q4 2025), 0.63 (Q3 2025), and 0.68 (Q2 2025) per Business Quant data.